Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements

Journal of Medical Virology

Volumn 50, Issue 3, 1996, Pages 254-262

  Khare, Suvarnalatha ^a   Kumar, Kotlo U ^a,b   Tang, Shou Ching ^a   Pater, Mary M ^a   Pater, Alan ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b HHMI   (United States)

Author keywords

Consensus; GREs; Hormone; HPV16 transcription; Protein DNA binding

Indexed keywords

DNA BINDING PROTEIN; GLUCOCORTICOID;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; PAPILLOMA VIRUS; PROMOTER REGION; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; CELLS, CULTURED; CONSENSUS SEQUENCE; DEXAMETHASONE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GLUCOCORTICOIDS; HELA CELLS; HORMONES; HUMANS; MUTAGENESIS, SITE-DIRECTED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RATS; REGULATORY SEQUENCES, NUCLEIC ACID; REPRESSOR PROTEINS; UP-REGULATION;

HUMAN PAPILLOMA VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 0029824048     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199611)50:3<254::AID-JMV8>3.0.CO;2-8     Document Type: Article

References (47)

1. Ausbel FM, Brent R, Kingston R, Noore D, Seidman J, Smith J, Struhl K (1994): "Current Protocols in Molecular Biology." New York: John Wiley and Sons, Inc.
2. Beato M, Herrlich P, Schutz G (1995): Steroid hormone receptors: many actors in search of a plot. Cell 83:851-858.
3. Bohkman JV, Urmancheyeva AF (1989): Cervix uteri cancer and pregnancy. European Journal of Gynecology Oncology 10:406-411.
4. Bornstein J, Rahat MA, Abramovici H (1995): Etiology of cervical cancer: current concepts. Obstetrical and Gynecological Survey 50:146-154.
5. Brinton LA, Herrero R, Reeves WC, Gaitan E, Tenorio F (1993): Risk factors for cervical cancer by histology. Gyneological Oncology 51:301-306.
6. Cato ACB, Miksicek R, Schuetz G, Arnemann J, Beato M (1986): The hormone regulatory element of mouse mammary tumor virus mediates progesterone induction. EMBO Journal 5:2237-2240.
7. Chan WK, Klock G, Bernard HU (1989): Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. Journal of Virology 63:3261-3269.
8. Chan WK, Chong T, Bernard H, Klock G (1990a): Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promoters through AP-1 binding sites. Nucleic Acids Research 18:763-769.
9. Chan WK, Chong T, Gloss B, Bernard H, Klock G (1990b): Papillomaviruses. In Howley P, Broker T (eds): "UCLA Symposium on Molecular and Cellular Biology," New Series. New York: John Wiley and Sons, Inc., vol 124, pp 169-178.
10. Chong T, Chan WK, Bernard HU (1990): Transcriptional activation of human papillomavirus type 16 by NF-1, AP-1, steroid receptors and a possibly novel transcription factor. Nucleic Acids Research 18:465-470.
11. Chong T, Apt D, Gloss B, Isa M, Bernard HU (1991): Enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors Oct-1, NFA, TEF-2, NF-1 and AP-1 participate in epithelial cell-specific transcription. Journal of Virology 65:5933-5943.
12. Dahlman-Wright K, Baumann H, McEvan IJ, Almlof T, Wright AP, Gustaffson AJ (1995): Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America 92:1699-1703.
13. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KK (1990): Transcription factor interaction: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272.
14. Feigner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987): Lipofection: a highly efficient, lipid-mediated DNA transfection procedure. Proceedings of the National Academy of Sciences of the United States of America 84:7413-7417.
15. Gloss B, Bernard HU, Seedorf K, Klock G (1987): The upstream regulatory region of the human papillomavirus-16 contains an E2-independent enhancer which is specific for cervical carcinoma cells and regulated by glycocorticoid hormones. The EMBO Journal 6:3735-3743.
16. Gloss B, Chong T, Bernard H-U (1989): Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer. Journal of Virology 63:1142-1152.
17. Gorman CM, Moffat MF, Howard BH (1982): Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Molecular and Cellular Biology 2:1044-1051.
18. Gronemeyer H (1993): Transcription activation by nuclear receptors. Journal of Receptor Research 13:667-691.
19. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evan RM (1985): Primary structure and expression of a functional glucocorticoid receptor cDNA. Nature 318:635-641.
20. Jenab S, Inturrisi CE (1995): Proenkephalin gene expression: interaction of glucocorticoid and cAMP regulatory elements. Biochemical and Biophysical Research Communications 210:589-599.
21. Khare S, Pater MM, Pater A (1995): Role of exogenous cofactors in HPV infection and oncogenesis. Papillomavirus Report 6:89-93.
22. Lawrence JB, Singer RH (1986): Intracellular localization of messenger RNAs for cytoskeletal proteins. Cell 45:407-415.
23. Lee K, Reddy EP, Reddy CD (1995): Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus. Journal of Biological Chemistry 270:24502-24508.
24. McDougall JK (1994): Immortalization and transformation of human cells by human papillomavirus. Current Topics in Microbiology and Immunology 186:101-119.
25. Mitchell PJ, Tjan R (1989): Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245:371-378.
26. Mittal R, Tsutsumi K, Pater A, Pater MM (1993a): Human papillomavirus type 16 expression in cervical keratinocytes: the role of progesterone and glucocorticoid hormones. Obstetrics and Gynecology 81:5-12.
27. Mittal R, Pater A, Pater MM (1993b): Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression and DNA-protein interactions. Journal of Virology 67:5656-5659.
28. Mittal R, Kumar KU, Pater A, Pater MM (1994): Differential regulation by c-jun and c-fos protooncogenes of hormone response from composite glucocorticoid response element in human papillomavirus type 16 regulatory region. Molecular Endocrinology 8:1701-1708.
29. Mows CC, Preiss T, Slater EF, Cao X, Verrijeer CF, van-Der-Vliet PC, Beato M (1994): Two independent pathways for transcription from the MMTV promoter. Journal of Steroid Biochemistry and Molecular Biology 51:21-32.
30. Nakshatri H, Pater MM, Pater A (1990): Ubiquitous and cell-type-specific protein interactions with human papillomavirus type 16 and type 18 enhancers. Virology 178:92-103.
31. Negrini BP, Schiffman MH, Kurman RJ, Barnes W, Launom L, Malley K, Brinton LA, Delgado G, Jones H, Tchabo JG, Lancaster WD (1990): Oral contraceptive use, human papillomavirus infection and risk of early cytological abnormalities of the cervix. Cancer Research 50:4070-4076.
32. Nürnberg W, Artuc M, Vorbrueggen G, Kalkbrenner F, Moelling K, Czarnetzki BM, Schadendorf D (1995): Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter. British Journal of Cancer 71:1018-1024.
33. O'Connor M, Bernard HU (1995): Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NF1 at a conserved composite regulatory element. Virology 207:77-88.
34. Parkin DM, Pisani P, Ferlay J (1993): Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer 54:594-606.
35. Pater MM, Mittal R, Pater A (1994): Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses. Trends in Microbiology 2:229-235.
36. Peto M, Tolle-Ersu I, Kreysch HG, Klock G (1995): Epidermal growth factor induction of HPV16 E6/E7 mRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. Journal of General Virology 76:1945-1958.
37. Rozansky D, Wu H, Tang K, Parmer RJ, O'Connor DT (1994): Glucocorticoid activation of chromogranin A gene expression. Journal of Clinical Investigation 94:3257-3268.
38. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS (1995): Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Molecular and Cellular Biology 15:943-953.
39. Sibbet G, Campo M (1990): Multiple interactions between cellular factors and the noncoding region of human papillomavirus type 16. Journal of General Virology 71:2699-2707.
40. Silva CM, Tully DB, Petch LA, Jewell CM (1987): Application of a protein-blotting procedure to the study of human glucocorticoid receptor interactions with DNA. Proceedings of the National Academy of Sciences of the United States of America 84:1744-1748.
41. Singh VB, Moudgil VK (1985): Phosphorylation of the rat liver glucocorticoid receptor. Journal of Biological Chemistry 28:4490-4498.
42. Stern E, Forsythe A, Yonkeles L, Coffelt C (1977): Steroid contraceptive use and cervical dysplasia: increased risk of progression. Science 236:1666-1671.
43. Tasset D, Tora L, Fromental C, Scheer E, Champon P (1990): Distinct class of transcriptional activating domains function by different mechanisms. Cell 62:1177-1187.
44. Tsutsumi K, Belaguli N, Qi S, Michalak TI, Gulliver WP, Pater A, Pater MM (1992): Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervix. American Journal of Pathology 140:255-261.
45. zur Hausen H (1977): Human papillomaviruses and their possible role in squamous cell carcinoma. Current Topics in Microbiology and Immunology 78:1-30.
46. zur Hausen H (1991): Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.
47. zur Hausen H, de Villiers EM (1994): Human papillomaviruses. Annual Review of Microbiology 48:427-447.